RCGP & SMMGP Managing Drug & Alcohol Problems in Primary Care Conference

Date03 November 2017
Duration1 day
Start Time09:00
End Time17:00
TypeConferences
LocationLondon
RCGP Accredited

£234.00

£234.00

If you are eligible for a discount, this will be shown at the checkout after you have logged in
Book now
Add to my calendar

The 22nd Managing Drug and Alcohol Problems in Primary Care Conference 2017 will take place on Friday 3rd November 2017 at RCGP HQ, 30 Euston Square, London.

This joint RCGP and SMMGP conference is the largest event in the UK for GPs, shared care workers, drug users, nurses and other primary care staff, specialists, commissioners and researchers interested in, and involved with the management of drug and alcohol users in primary care.

The conference will explore the roles primary care can play in drug and alcohol services, for example in the added value of being able to address coexisting health issues. Users of all ages need good general healthcare and this year's conference will focus on how we can improve screening, assessment and treatment of mental health problems. Primary care is well placed to reduce stigma often associated with these problems and can also deliver wider public health outcomes effectively (e.g smoking cessation / contraception /cervical smears/ Hep C diagnosis and treatment).

 Confirmed speakers

  • Dr Adam Winstock
  • Professor Sir Ian Gilmore
  • Dr Geraldine Strathdee
  • Professor Harry Sumnall
  • Dr George Ryan
  • Graham Parsons
  • Dr Caroline Shulman

MDAP Programme 2017 (Please note whilst we endeavour to present the programme as advertised, we reserve the right to amend timings and content)

Call for examples of best practice

If you would like to submit a paper, poster or media for the 22nd Managing Drug and Alcohol Problems in Primary Care Conference 2017, please complete and submit the application form by Friday 29 September. Click here to download application form

 

Principal Sponsor

Indivior is a global addiction/speciality pharmaceutical company with a legacy in substance misuse and dependency therapy. Indivior has a heritage of delivering treatment that focuses on the individual. This is represented in our name Indivior, which is a fusion of individual and endeavour –  Indivior endeavours to provide innovative treatment to meet unmet patients‘ needs.

 

Conference Supporters

  

                           
Martindale Pharma has many years of experience in the treatment of opioid addiction in the UK, Iceland and in Scandinavia, during which time we have worked in close collaboration with governments, leading addiction treatment providers and healthcare professionals working in opioid addiction. It is this depth of expertise that makes us a market leader and a highly trusted supplier of opioid addiction products.   Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North and South America, Europe, and Asia Pacific.
                 
VenueRCGP, 30 Euston Square, London, NW1 2FB
Maximum capacity200
EmailRCGP Conferences
Phone020 3188 7658
ContactRCGP Conferences

Facilities

  • Refreshments
  • Hearing Loop
  • Lunch
  • Wi-fi

Sponsorship and exhibition opportunities 

Email               RCGP Sponsorship

Phone              020 3188 7506

Find courses & events

The item has been added to your basket.

Continue shopping

Go to basket

This item is out of stock.

Continue shopping

The item is out of stock.

Yes Continue shopping

An error occured adding your item to the basket:

Continue shopping